ITIH2 and invasive breast carcinoma: In 44% (81/185) of invasive carcinomas of the breast, ITIH2 expression was strongly reduced or completely lost (Figure 4E and 4F) while 56% of invasive carcinomas (104/185) maintained moderate to strong ITIH2 expression (Figure 4G and 4H).